Amesite Inc. (AMST)
NASDAQ: AMST · Real-Time Price · USD
0.8825
+0.0400 (4.75%)
At close: Oct 15, 2026, 4:00 PM EDT
0.8953
+0.0128 (1.45%)
After-hours: Oct 15, 2026, 7:09 PM EDT
Company Description
Amesite Inc., a technology company, engages in the development and marketing of B2C and B2B AI-driven solutions in the United States.
The company products include Amesite Engage, that leverages proprietary AI infrastructure, offering cutting-edge applications that cater to both individual and professional needs; and LynkMagic, provides enterprise AI solutions for healthcare and related organizations.
It also provides NurseMagic, mobile healthcare app, streamlines creation of nursing notes and documentation tasks, enhances patient communication, and offers personalized guidance to nurses on patient care, medications, and handling challenging workplace situation.
Amesite Inc. is headquartered in Detroit, Michigan.
Amesite Inc.
| Country | United States |
| IPO Date | Sep 25, 2020 |
| Industry | Software - Application |
| Sector | Technology |
| Employees | 5 |
| CEO | Ann Sastry |
Contact Details
Address: 607 Shelby Street, Suite 700 Detroit, Michigan 48226 United States | |
| Phone | 734 876 8141 |
| Website | amesite.com |
Stock Details
| Ticker Symbol | AMST |
| Exchange | NASDAQ |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| IPO Price | $5.00 |
| CIK Code | 1807166 |
| CUSIP Number | 031094204 |
| ISIN Number | US0310942042 |
| Employer ID | 82-3431717 |
| SIC Code | 7372 |
Key Executives
| Name | Position |
|---|---|
| Dr. Ann Marie Sastry Ph.D. | Chairperson, President and Chief Executive Officer |
| Sarah Berman CPA | Principal Financial and Accounting Officer |
| Kalie Wortinger | Senior Manager of Engineering |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 14, 2026 | ARS | Filing |
| Oct 14, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Oct 14, 2026 | DEF 14A | Other definitive proxy statements |
| Oct 2, 2026 | PRE 14A | Other preliminary proxy statements |
| Sep 23, 2026 | 10-K | Annual Report |
| Sep 17, 2026 | 8-K | Current Report |
| Sep 11, 2026 | 8-K | Current Report |
| Jul 30, 2026 | S-8 | Securities to be offered to employees in employee benefit plans |
| Jul 20, 2026 | 8-K | Current Report |
| Jul 17, 2026 | 424B5 | Filing |